Kim GA - Search Results

1

High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study.

Yoon JS, Hong JH, Park SY, Kim SU, Kim HY, Kim JY, Hur MH, Park MK, Lee YB, Lee HA, Kim GA, Sinn DH, Park SJ, Lee YJ, Kim YJ, Yoon JH, Lee JH. Yoon JS, et al. Among authors: kim ga. Aliment Pharmacol Ther. 2024 Apr;59(8):973-983. doi: 10.1111/apt.17909. Epub 2024 Feb 22. Aliment Pharmacol Ther. 2024. PMID: 38389319

2

Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study.

Kim MA, Kim SU, Sinn DH, Jang JW, Lim YS, Ahn SH, Shim JJ, Seo YS, Baek YH, Kim SG, Kim YS, Kim JH, Choe WH, Yim HJ, Lee HW, Kwon JH, Lee SW, Jang JY, Kim HY, Park Y, Kim GA, Yang H, Lee HA, Koh M, Lee YS, Kim M, Chang Y, Kim YJ, Yoon JH, Zoulim F, Lee JH. Kim MA, et al. Among authors: kim hy, kim yj, kim su, kim sg, kim m, kim ys, kim ga, kim jh. Gut. 2020 Dec;69(12):2214-2222. doi: 10.1136/gutjnl-2019-320015. Epub 2020 Mar 24. Gut. 2020. PMID: 32209606

3

Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B.

Choi WM, Kim GA, Choi J, Choi GH, Lee YB, Sinn DH, Lim YS. Choi WM, et al. Among authors: kim ga. Gut. 2024 Mar 7;73(4):649-658. doi: 10.1136/gutjnl-2023-330225. Gut. 2024. PMID: 37813567

4

Risk of Hepatitis C Virus Transmission through Acupuncture: A Systematic Review and Meta-Analysis.

Hyun MH, Kim JH, Jang JW, Song JE, Song DS, Lee HW, Cho YY, Kim GA, Yoon EL, Sinn DH, Kim SS, Yim SY, Yang H, An J. Hyun MH, et al. Among authors: kim ss, kim ga, kim jh. Korean J Gastroenterol. 2023 Sep 25;82(3):127-136. doi: 10.4166/kjg.2023.060. Korean J Gastroenterol. 2023. PMID: 37743811 Free article.

5

Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients.

Kim GA, Han S, Choi GH, Choi J, Lim YS. Kim GA, et al. Aliment Pharmacol Ther. 2020 Jun;51(11):1169-1179. doi: 10.1111/apt.15725. Epub 2020 Apr 14. Aliment Pharmacol Ther. 2020. PMID: 32291781

6

High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation.

Choi GH, Kim GA, Choi J, Han S, Lim YS. Choi GH, et al. Among authors: kim ga. Aliment Pharmacol Ther. 2019 Jul;50(2):215-226. doi: 10.1111/apt.15311. Epub 2019 May 28. Aliment Pharmacol Ther. 2019. PMID: 31135074

7

Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study.

Kim SE, Jang ES, Ki M, Gwak GY, Kim KA, Kim GA, Kim DY, Kim DJ, Kim MW, Kim YS, Kim YS, Kim IH, Kim CW, Kim HD, Kim HJ, Park NH, Baik SK, Suh JI, Song BC, Song IH, Yeon JE, Lee BS, Lee YJ, Jung YK, Chung WJ, Cho SB, Cho EY, Cho HC, Cheon GJ, Chae HB, Choi D, Choi SK, Choi HY, Tak WY, Heo J, Jeong SH. Kim SE, et al. Among authors: kim ih, kim hj, kim cw, kim dy, kim ka, kim dj, kim ga, kim mw, kim ys, kim hd. J Korean Med Sci. 2018 Sep 12;33(42):e264. doi: 10.3346/jkms.2018.33.e264. eCollection 2018 Oct 15. J Korean Med Sci. 2018. PMID: 30310365 Free PMC article.

8

Proteome Multimarker Panel With Multiple Reaction Monitoring-Mass Spectrometry for Early Detection of Hepatocellular Carcinoma.

Yeo I, Kim GA, Kim H, Lee JH, Sohn A, Gwak GY, Lee JH, Lim YS, Kim Y. Yeo I, et al. Among authors: kim h, kim ga, kim y. Hepatol Commun. 2020 Mar 13;4(5):753-768. doi: 10.1002/hep4.1500. eCollection 2020 May. Hepatol Commun. 2020. PMID: 32363324 Free PMC article.

9

Letter: moderate levels of serum hepatitis B virus DNA alone are not associated with increased risk of hepatocellular carcinoma in chronic hepatitis B patients. Authors' reply.

Kim GA, Lim YS. Kim GA, et al. Aliment Pharmacol Ther. 2020 Aug;52(3):576-577. doi: 10.1111/apt.15881. Aliment Pharmacol Ther. 2020. PMID: 32656844 No abstract available.

10

Editorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg-positive versus HBeAg-negative patients. Authors' reply.

Kim GA, Lim YS. Kim GA, et al. Aliment Pharmacol Ther. 2020 Jun;51(12):1440-1441. doi: 10.1111/apt.15794. Aliment Pharmacol Ther. 2020. PMID: 32445524 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

453 results

Search Page